Dose‐dependent metabolic excretion of bromobenzene and its possible relationship to hepatotoxicity in rats
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 14 (2-3), 379-391
- https://doi.org/10.1080/15287398409530587
Abstract
Male Sprague‐Dawley rats received an intraperitoneal injection of 0.25‐, 0.5‐, 1.0‐, 2.5‐, and 5.0‐mmol/kg dose of bromobenzene in corn oil. The metabolic fate of bromo‐benzene was studied by measuring its various urinary metabolites 24 h following bromobenzene administration. The hepatotoxicity of bormobenzene was estimated by determination of the serum glutamic‐oxaloacetic and glutamic‐pyruvic transaminase activities (SGOT and SGPT) 24 h after dosing. Treatment of rats with bromobenzene at up to 0.5 mmol/kg did not influence the transaminase activities, but significant increases in such activities began to manifest at a dose of 1 mmol/kg. However, no further increase in hepatotoxic response was induced on exposure to higher doses (2.5 and 5.0 mmol/kg) of bromobenzene. The urinary excretion of toxic doses of bromobenzene was nonlinear, based on the quantitative composition of various urinary metabolites. Furthermore, the fraction of the dose converted to thioethers, p‐bromophenol, m‐bromophenol, and total phenolic metabolites decreased with increasing toxic dose, suggesting their formation to be capacity‐limited. The ratios of thioethers to total phenolic metabolites, of thioethers to p‐bromophenol, and of thioethers to o‐bromo‐phenol decreased with increasing dose of bromobenzene. The correlation of the dose‐dependent fate of metabolic excretion of bromobenzene with the results of the dose‐hepatotoxic response curves supports the conclusion that there exists an apparent threshold dose (∼1–2.5 mmol/kg) for the toxic effects of bromobenzene that coincides with saturation of the metabolic pathways involving both glutathione/glutathione S‐transferase(s) and formation of certain phenolic derivatives for its detoxification. All these results further suggest a role of a saturable, metabolic activation process involving 3,4‐epoxide rather than 2,3‐epoxide of bromobenzene in the development of its hepatotoxicity.This publication has 17 references indexed in Scilit:
- Stereoselective formation of bromobenzene glutathione conjugatesChemico-Biological Interactions, 1982
- Studies on liver toxicantsArchives of Toxicology, 1980
- Hepatic microsomal epoxidation of bromobenzene to phenols and its toxicological implicationToxicology and Applied Pharmacology, 1979
- Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic MetabolitePharmacology, 1974
- Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbonsExperimental and Molecular Pathology, 1973
- Determination of serum creatinine by a direct colorimetric methodClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- Possible Mechanism of Liver Necrosis Caused by Aromatic Organic CompoundsProceedings of the National Academy of Sciences, 1971
- Deuterium migration during the acid-catalyzed dehydration of 6-deuterio-5,6-dihydroxy-3-chloro-1,3-cyclohexadi-ene, a nonenzymic model for the NIH shiftJournal of the American Chemical Society, 1967
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959
- TRANSAMINASE ACTIVITY IN HUMAN BLOODJournal of Clinical Investigation, 1955